Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICL670 Safety in Iron Overload Intolerant Patients
NCT01044186Phase 2Completed
- Sponsor
- Novartis
- Start
- Jun 2003
- Primary completion
- Dec 2007
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of deferasirox in Transfusional Iron Overload (TIO), sponsored by Novartis. Started Jun 2003; status: completed.
02
Drugs
deferasirox
03
Conditions
Transfusional Iron Overload (TIO)
Beyond the preview
Go deeper on NCT01044186.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01044186.